Key result
ECGI-guided ablation linked to ~46% arrhythmia freedom off drugs at one year in recurrent post-PVI AF.
Why the study?
Mechanisms sustaining persistent AF remain unclear, prompting evaluation of clinical outcomes and ablation response to potential drivers in patients with recurrent persistent AF after PVI.
Does ECGI-guided ablation of potential drivers improve freedom from atrial arrhythmia in patients with recurrent persistent AF following PVI?
Cohort (n=37)
Open-label
No
Does ECGI-guided ablation of potential drivers improve freedom from atrial arrhythmia in patients with recurrent persistent AF following PVI?
In patients with recurrent persistent AF despite prior PVI, ECGI-guided ablation of potential drivers resulted in a 54% freedom from atrial arrhythmia at 1 year.
May support ECGI-guided driver ablation in recurrent persistent AF post-PVI; leaves open efficacy in randomized trials.
Background: Mechanisms sustaining persistent atrial fibrillation (AF) remain unclear. Objectives: The study sought to evaluate both the clinical outcomes and response to ablation of potential drivers in patients with recurrent persistent AF recurrence following pulmonary vein isolation (PVI). Methods: A total of 100 patients with persistent AF of <2 years' duration underwent cryoballoon PVI (ECGI phenotyping of persistent AF based on driver burden and distribution to predict response to pulmonary vein isolation). Patients with documented recurrence of atrial arrhythmia within 12 months were recruited and underwent repeat PVI (if needed) followed by ablation of potential drivers (PDs) identified by electrocardiographic imaging (ECGI). PDs were defined as rotational activity >1.5 revolutions or focal activations. Cycle lengths were measured pre- and postablation. The primary outcome was freedom from atrial arrhythmia off antiarrhythmic drugs at 1 year as per guidelines. Results: Of 37 patients recruited, 26 had recurrent AF and underwent ECGI-guided ablation of PDs. An average of 6.4 ± 2.7 PDs were targeted per patient. The mean ablation time targeting PDs was 15.5 ± 6.9 minutes. An ablation response occurred in 20 patients (AF termination in 6, cycle length prolongation ≥10% in 14). At 1 year, 14 (54%) of 26 patients were free from arrhythmia, and 12 (46%) of 26 were off antiarrhythmic drugs. Considering the 96 patients who completed follow-up out of the original cohort of 100 patients undergoing cryoablation in this staged strategy, freedom from arrhythmia at 1 year following the last procedure was 72 (75%) of 96, or 70 (73%) of 96 off antiarrhythmic drugs. Conclusions: In patients with recurrent AF despite PVI, ECGI-guided ablation caused an acute response in a majority with reasonable long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Dhillon et al. (2023) conducted a cohort in Recurrent persistent atrial fibrillation following pulmonary vein isolation (n=37). ECGI-guided ablation of potential drivers was evaluated on Freedom from documented atrial arrhythmia lasting ≥30 seconds following a 3-month blanking period off antiarrhythmic drugs at 1 year. In patients with recurrent persistent atrial fibrillation despite pulmonary vein isolation, ECGI-guided ablation of potential drivers resulted in 46% freedom from atrial arrhythmia off antiarrhythmic drugs at 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: